RECATICIMAB

UNII:	20IE6M67UX
Formula:
Preferred Substance Name:	RECATICIMAB
GSRS Full Record:	20IE6M67UX i

2361290-85-7
IMMUNOGLOBULIN G1 (256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID), ANTI-(NEURAL APOPTOSIS-REGULATED PROTEINASE 1) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .GAMMA.1-CHAIN), DISULFIDE WITH (3-VALINE,5-SERINE,49-SERINE,66-ASPARTIC ACID) HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1 (256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID), ANTI-(PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .GAMMA.1-CHAIN), DISULFIDE WITH (3-VALINE,5-SERINE,49-SERINE,66-ASPARTIC ACID) HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEINE CONVERTASE 9, PC9)), MONOCLONAL ANTIBODY (RECATICIMAB)
RECATICIMAB [INN]
SHR 1209 [WHO-DD]
SHR1209
SHR-1209

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RECATICIMAB

Synonyms and Mappings

Resources